# Amwell® Announces Results for First Quarter 2025
Canonical URL: https://biopharmsignal.com/news/AMWL/amwell-announces-results-for-first-quarter-2025-56879a81
Ticker: AMWL
Company: American Well
Source: American Well
Published: 2025-05-01 20:05 EST
## Summary

Amwell® (NYSE: AMWL) a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first quarter e...

## Article Body
Amwell ® (NYSE: AMWL) a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first quarter ended March 31. Visit Amwell’s investor relations website at investors.amwell.com to view the first quarter 2025 earnings report.

The company will host a conference call to discuss its financial results today at 5 p.m. ET, May 1. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/9tn5fcf6 . A replay of the call will be available via webcast shortly after the completion of the call, at investors.amwell.com .

About Amwell

Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn .

Contacts

Media: Angela Vogen Press@amwell.com

Investors: Sue Dooley sue.dooley@amwell.com
## Recent Company News
- 2026-07-24 12:00 EST — [Amwell® to report second quarter 2026 operating results](https://biopharmsignal.com/news/AMWL/amwell-to-report-second-quarter-2026-operating-results-05b3d1ab) — Source: American Well
- 2026-05-18 11:05 EST — [Nature Human Behaviour study finds SilverCloud® by Amwell® reduced prevalence of mental disorders over two years at scale](https://biopharmsignal.com/news/AMWL/nature-human-behaviour-study-finds-silvercloud-by-amwell-reduced-prevalence-of-m-dd7dd711) — Source: American Well
- 2026-05-11 20:05 EST — [Amwell® to Participate in Upcoming Investor Conference](https://biopharmsignal.com/news/AMWL/amwell-to-participate-in-upcoming-investor-conference-c285d2c6) — Source: American Well
- 2026-05-05 20:05 EST — [Amwell® Announces Results for First Quarter 2026](https://biopharmsignal.com/news/AMWL/amwell-announces-results-for-first-quarter-2026-1abdf658) — Source: American Well
- 2026-04-20 20:05 EST — [Amwell® to report first quarter 2026 operating results](https://biopharmsignal.com/news/AMWL/amwell-to-report-first-quarter-2026-operating-results-ae059d6a) — Source: American Well
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)